Symbols

ALXO

ALX Oncology·NASDAQ

--(--)

5.31 / 10

Netural

The fund flow profile scores 7.88/10, demonstrating robust fund flow characteristics. Favorable overall, block, Large, and Extra-large movements are tempered by challenging Small and Medium dynamics, supporting positive flow assessment. Analyst consensus points to overwhelmingly bullish analyst consensus with strong conviction. Distribution analysis: Strong Buy(50.0%), Buy(50.0%) among 2 research opinions, supported by 2.75 historical weighted rating.

Fund Flow Rating

Analyst RatingStrong Buy

Wall Street Opinions

Strong Buy

50%

Buy

50%

Hold

Sell

Strong Sell

Date2026-03-19

InstitutionWells Fargo

Times predicted1

Historical Win Rate0.0%

Is money flowing into or out of ALXO?

ALXO holds a Bearish analyst rating, with 50% of experts assigning a Strong Buy grade. Factoring in net Inflows from order flow data, the comprehensive Sentiment Score stands at 5.31/10 (Netural).